INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio update as at 30 April 2010
Total Net Assets |
£106.3m |
NAV per share |
173.6p |
Share Price |
140.3p |
Total value of unquoted investments |
£23.0m |
Total number of portfolio companies |
58 |
Cash |
4% |
Cash committed and reserved to unquoted investments |
14% |
Portfolio companies with < 1 year of cash |
7% |
Top Ten Holdings
Company Name |
% NAV |
Celgene |
7.01 |
Micromet |
5.83 |
Amgen |
5.49 |
Shire |
4.63 |
Alexion Pharmaceuticals |
3.86 |
Gilead Sciences |
3.64 |
Genzyme |
3.40 |
EUSA Pharma |
2.88 |
Oxagen |
2.74 |
Wright Medical Group |
2.67 |
|
----------- |
Total |
42.15 |
Geographical Allocation |
% |
United States |
76 |
Europe |
18 |
Cash |
4 |
Australia |
2 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
74 |
Unquoted |
22 |
Cash |
4 |
|
----------- |
|
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
20 MAY 2010